Cargando…
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
BACKGROUND: Metastasis is the primary cause of death in cancer patients, and its management is still a major challenge. Epithelial to mesenchymal transition (EMT) has been implicated in the process of cancer metastasis, and its pharmacological interference holds therapeutic promise. METHODS: Traf2-...
Autores principales: | Sugano, Teppei, Masuda, Mari, Takeshita, Fumitaka, Motoi, Noriko, Hirozane, Toru, Goto, Naoko, Kashimoto, Shigeki, Uno, Yuko, Moriyama, Hideki, Sawa, Masaaki, Nagakawa, Yuichi, Tsuchida, Akihiko, Seike, Masahiro, Gemma, Akihiko, Yamada, Tesshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782820/ https://www.ncbi.nlm.nih.gov/pubmed/33244122 http://dx.doi.org/10.1038/s41416-020-01162-3 |
Ejemplares similares
-
Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma
por: Sekita, Tetsuya, et al.
Publicado: (2020) -
Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer
por: Takahashi, Hidenori, et al.
Publicado: (2015) -
Direct conversion of osteosarcoma to adipocytes by targeting TNIK
por: Hirozane, Toru, et al.
Publicado: (2021) -
Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor
por: Tan, Zhi, et al.
Publicado: (2016) -
Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK)
por: Ma, Lushun, et al.
Publicado: (2022)